Triple
T195395
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Biogen |
E3807
|
entity |
| Predicate | hasNotableDrug |
P7501
|
FINISHED |
| Object | Spinraza |
E24879
|
NE FINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Spinraza | Statement: [Biogen, hasNotableDrug, Spinraza]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Spinraza Context triple: [Biogen, hasNotableDrug, Spinraza]
-
A.
Spinraza
chosen
Spinraza is a prescription medication used to treat spinal muscular atrophy (SMA) by modifying SMN2 gene expression to increase production of survival motor neuron (SMN) protein.
-
B.
Aduhelm
Aduhelm is an Alzheimer’s disease drug developed by Biogen that targets amyloid-beta plaques in the brain.
-
C.
Tysabri
Tysabri is a monoclonal antibody medication primarily used to treat relapsing forms of multiple sclerosis and Crohn’s disease.
-
D.
Ionis Pharmaceuticals
Ionis Pharmaceuticals is a biotechnology company specializing in the discovery and development of RNA-targeted therapeutics using antisense technology.
-
E.
Vumerity
Vumerity is an oral prescription medication used to treat relapsing forms of multiple sclerosis in adults.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: hasNotableDrug Context triple: [Biogen, hasNotableDrug, Spinraza]
-
A.
hasNotableWord
Indicates that an entity is associated with a word or term that is considered notable, distinctive, or significant in some context.
-
B.
hasNotableSubject
Indicates that an entity is associated with a subject that is particularly significant, prominent, or noteworthy in relation to it.
-
C.
hasNotableFeature
Indicates that an entity possesses a specific characteristic, trait, or attribute that is considered significant or noteworthy.
-
D.
hasNotableInterchange
Indicates that there exists a significant or well-known point of exchange, connection, or transfer between the related entities.
-
E.
hasNotableMember
Indicates that a group, organization, or collection includes at least one member who is distinguished or noteworthy in some significant way.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a2548debd48190ae3a06d6e65b53c6 |
completed | Feb. 28, 2026, 2:35 a.m. |
| NER | Named-entity recognition | batch_69a25969425081908e178db8ba4631c2 |
completed | Feb. 28, 2026, 2:56 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69a31c91b22c8190a1d04983ae4fd793 |
completed | Feb. 28, 2026, 4:49 p.m. |
| PD | Predicate disambiguation | batch_69a25677da14819094cd02868fd30c83 |
completed | Feb. 28, 2026, 2:44 a.m. |
| PDg | Predicate description generation | batch_69a258b30f6c8190be2181f30c40e04d |
completed | Feb. 28, 2026, 2:53 a.m. |
Created at: Feb. 28, 2026, 2:41 a.m.